2024 Q4 Form 10-Q Financial Statement
#000149315224044515 Filed on November 12, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
Revenue | $669.4K | $0.00 | |
YoY Change | |||
Cost Of Revenue | $191.9K | ||
YoY Change | |||
Gross Profit | $477.5K | ||
YoY Change | |||
Gross Profit Margin | 71.34% | ||
Selling, General & Admin | $42.98K | $48.99K | |
YoY Change | -12.26% | 1980.3% | |
% of Gross Profit | 9.0% | ||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $5.998K | $1.298K | |
YoY Change | 362.1% | 0.0% | |
% of Gross Profit | 1.26% | ||
Operating Expenses | $210.9K | $325.3K | |
YoY Change | -35.17% | -4.05% | |
Operating Profit | $266.6K | -$325.3K | |
YoY Change | -181.97% | -4.05% | |
Interest Expense | -$10.10K | $1.550M | |
YoY Change | -100.65% | 454.48% | |
% of Operating Profit | -3.79% | ||
Other Income/Expense, Net | -$10.10K | $1.550M | |
YoY Change | -100.65% | 454.47% | |
Pretax Income | $256.5K | $1.225M | |
YoY Change | -79.05% | -2160.05% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | $256.5K | $1.225M | |
YoY Change | -79.05% | -2160.05% | |
Net Earnings / Revenue | 38.32% | ||
Basic Earnings Per Share | $0.00 | $0.00 | |
Diluted Earnings Per Share | $0.00 | $0.00 | |
COMMON SHARES | |||
Basic Shares Outstanding | 14.69B shares | 14.69B shares | |
Diluted Shares Outstanding | 14.69B shares | 14.54B shares |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $292.9K | $13.19K | |
YoY Change | 2120.32% | 261.37% | |
Cash & Equivalents | $292.9K | $13.19K | |
Short-Term Investments | |||
Other Short-Term Assets | $225.0K | ||
YoY Change | |||
Inventory | |||
Prepaid Expenses | $225.0K | ||
Receivables | $156.6K | ||
Other Receivables | $0.00 | ||
Total Short-Term Assets | $674.5K | $13.19K | |
YoY Change | 5013.5% | -65.25% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $120.6K | $16.45K | |
YoY Change | 633.01% | -23.99% | |
Goodwill | $7.686M | $2.890M | |
YoY Change | 165.94% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $7.831M | $6.506M | |
YoY Change | 20.36% | 1650.71% | |
Total Long-Term Assets | $7.831M | $6.506M | |
YoY Change | 20.36% | 1650.71% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $674.5K | $13.19K | |
Total Long-Term Assets | $7.831M | $6.506M | |
Total Assets | $8.506M | $6.520M | |
YoY Change | 30.46% | 1491.69% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $50.35K | $10.42K | |
YoY Change | 383.05% | -66.85% | |
Accrued Expenses | $110.9K | $114.6K | |
YoY Change | -3.2% | 120.56% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $463.3K | $3.590M | |
YoY Change | -87.1% | 1087.72% | |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $6.717M | $6.673M | |
YoY Change | 0.65% | 472.47% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.717M | $6.673M | |
Total Long-Term Liabilities | $0.00 | $0.00 | |
Total Liabilities | $6.717M | $6.673M | |
YoY Change | 0.65% | 472.47% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$166.4M | -$166.3M | |
YoY Change | 0.09% | -0.15% | |
Common Stock | $162.9M | $161.5M | |
YoY Change | 0.89% | -1.76% | |
Preferred Stock | $1.861M | $1.702M | |
YoY Change | 9.33% | 22.9% | |
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $1.789M | -$3.053M | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $8.506M | $6.520M | |
YoY Change | 30.46% | 1491.69% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $256.5K | $1.225M | |
YoY Change | -79.05% | -2160.05% | |
Depreciation, Depletion And Amortization | $5.998K | $1.298K | |
YoY Change | 362.1% | 0.0% | |
Cash From Operating Activities | $217.1K | -$102.7K | |
YoY Change | -311.35% | -67.98% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | ||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -$40.00K | $97.62K | |
YoY Change | -140.98% | ||
NET CHANGE | |||
Cash From Operating Activities | $217.1K | -$102.7K | |
Cash From Investing Activities | |||
Cash From Financing Activities | -$40.00K | $97.62K | |
Net Change In Cash | $177.1K | -$5.110K | |
YoY Change | -3566.03% | -98.41% | |
FREE CASH FLOW | |||
Cash From Operating Activities | $217.1K | -$102.7K | |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q3 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000932021 | |
CY2024Q3 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q3 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q3 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | |
CY2024Q3 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q3 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q3 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q3 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2024Q3 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q3 | dei |
Security12b Title
Security12bTitle
|
Common Stock | |
CY2024Q3 | dei |
Trading Symbol
TradingSymbol
|
GTLL | |
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
14688440097 | shares |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
292861 | usd |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
115747 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
156610 | usd |
CY2024Q3 | us-gaap |
Goodwill
Goodwill
|
7685636 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
25000 | usd |
CY2024Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
7831245 | usd |
CY2024Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
7837243 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
8505716 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
8362682 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
50348 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
90785 | usd |
CY2024Q3 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
95745 | usd |
CY2024Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
85650 | usd |
CY2024Q3 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
15160 | usd |
CY2024Q3 | GTLL |
Notes Payable Third Parties Current
NotesPayableThirdPartiesCurrent
|
395000 | usd |
CY2024Q2 | GTLL |
Notes Payable Third Parties Current
NotesPayableThirdPartiesCurrent
|
435000 | usd |
CY2024Q2 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
68269 | usd |
CY2024Q3 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
5764227 | usd |
CY2024Q3 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
327947 | usd |
CY2024Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
327947 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6716696 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6830211 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
6716696 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
6830211 | usd |
CY2024Q3 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
CY2024Q3 | dei |
Entity File Number
EntityFileNumber
|
000-25668 | |
CY2024Q3 | dei |
Entity Registrant Name
EntityRegistrantName
|
GLOBAL TECHNOLOGIES, LTD | |
CY2024Q3 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2024Q3 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
86-0970492 | |
CY2024Q3 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 105 | |
CY2024Q3 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Parsippany | |
CY2024Q3 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NJ | |
CY2024Q3 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
07054 | |
CY2024Q3 | dei |
City Area Code
CityAreaCode
|
(973) | |
CY2024Q3 | dei |
Local Phone Number
LocalPhoneNumber
|
233-5151 | |
CY2024Q3 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q3 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2025 | |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
usd | |
CY2023Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
usd | |
CY2023Q3 | us-gaap |
Gross Profit
GrossProfit
|
usd | |
CY2024Q3 | GTLL |
Consulting Services
ConsultingServices
|
usd | |
CY2023Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
usd | |
CY2024Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
usd | |
CY2024Q3 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
usd | |
CY2024Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | |
CY2024Q3 | us-gaap |
Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
|
usd | |
CY2024Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
usd | |
CY2024Q3 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | |
CY2024Q3 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
usd | |
CY2023Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
usd | |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2023Q3 | GTLL |
Payments On Convertible Notes Payable
PaymentsOnConvertibleNotesPayable
|
usd | |
CY2024Q3 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
usd | |
CY2024Q3 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
usd | |
CY2024Q3 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2023Q3 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2024Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2023Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2024Q3 | GTLL |
Issuance Of Common Stock For Debt
IssuanceOfCommonStockForDebt
|
usd | |
CY2023Q3 | GTLL |
Issuance Of Common Stock For Debt
IssuanceOfCommonStockForDebt
|
usd | |
CY2024Q3 | GTLL |
Accrual For Contingent Consideration Of Acquisition Of Foxx Trott Tango Llc
AccrualForContingentConsiderationOfAcquisitionOfFoxxTrottTangoLlc
|
usd | |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
usd | |
CY2024Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
usd | |
CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
usd | |
CY2024Q3 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q3 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
8 Campus Drive | |
CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
184692 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
225000 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
225000 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
674471 | usd |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
525439 | usd |
CY2024Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
40754 | usd |
CY2024Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
34756 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
120609 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
126607 | usd |
CY2024Q2 | us-gaap |
Goodwill
Goodwill
|
7685636 | usd |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
25000 | usd |
CY2024Q2 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
58333 | usd |
CY2024Q3 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
68269 | usd |
CY2024Q2 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
5764227 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2024Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2024Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
162898727 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
162898727 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
|
1861142 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
|
1861142 | usd |
CY2024Q3 | GTLL |
Exchange Shares To Be Issued
ExchangeSharesToBeIssued
|
1921409 | usd |
CY2024Q2 | GTLL |
Exchange Shares To Be Issued
ExchangeSharesToBeIssued
|
1921409 | usd |
CY2024Q3 | GTLL |
Common Stock To Be Issued Value
CommonStockToBeIssuedValue
|
30000 | usd |
CY2024Q2 | GTLL |
Common Stock To Be Issued Value
CommonStockToBeIssuedValue
|
30000 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-166409747 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-166666296 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1789020 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1532471 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8505716 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8362682 | usd |
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
669431 | usd |
CY2024Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
191889 | usd |
CY2024Q3 | us-gaap |
Gross Profit
GrossProfit
|
477542 | usd |
CY2024Q3 | us-gaap |
Officers Compensation
OfficersCompensation
|
25000 | usd |
CY2023Q3 | us-gaap |
Officers Compensation
OfficersCompensation
|
25000 | usd |
CY2024Q3 | us-gaap |
Depreciation
Depreciation
|
5998 | usd |
CY2023Q3 | us-gaap |
Depreciation
Depreciation
|
1298 | usd |
CY2023Q3 | GTLL |
Consulting Services
ConsultingServices
|
250000 | usd |
CY2024Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
136916 | usd |
CY2024Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
42984 | usd |
CY2023Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
48991 | usd |
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
210898 | usd |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
325289 | usd |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
266644 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-325289 | usd |
CY2023Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
1920292 | usd |
CY2024Q3 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
10095 | usd |
CY2023Q3 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
72099 | usd |
CY2023Q3 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
298082 | usd |
CY2024Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-10095 | usd |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1550111 | usd |
CY2024Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
256549 | usd |
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1224822 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
256549 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1224822 | usd |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14688440097 | shares |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14688440097 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14539553430 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14539553430 | shares |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4528007 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
250000 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1224822 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3053185 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1532471 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1532471 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
256549 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
256549 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1789020 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1789020 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
256549 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1224822 | usd |
CY2023Q3 | us-gaap |
Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
|
25000 | usd |
CY2023Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
1920292 | usd |
CY2024Q3 | us-gaap |
Depreciation
Depreciation
|
5998 | usd |
CY2023Q3 | us-gaap |
Depreciation
Depreciation
|
1298 | usd |
CY2023Q3 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
250000 | usd |
CY2023Q3 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
298082 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-28082 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-40437 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-21234 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
10095 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
27098 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-43173 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
12500 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
217114 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-102726 | usd |
CY2024Q3 | GTLL |
Payments On Convertible Notes Payable
PaymentsOnConvertibleNotesPayable
|
-40000 | usd |
CY2023Q3 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
77616 | usd |
CY2023Q3 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
20000 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-40000 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
97616 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
177114 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-5110 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
115747 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
18300 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
292861 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
13190 | usd |
CY2023Q3 | GTLL |
Accrual For Contingent Consideration Of Acquisition Of Foxx Trott Tango Llc
AccrualForContingentConsiderationOfAcquisitionOfFoxxTrottTangoLlc
|
3400000 | usd |
CY2024Q3 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<p id="xdx_800_eus-gaap--BasisOfAccounting_zh954l0nFIG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE B – <span id="xdx_82C_zEHIPbiACtu9">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2024 and the results of operations, changes in stockholders’ equity, and cash flows for the periods presented. The results of operations for the three months ended September 30, 2024 are not necessarily indicative of the operating results for the full fiscal year or any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024 as filed with the Securities and Exchange Commission on September 25, 2024. The Company’s accounting policies are described in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2024, and updated, as necessary, in this Quarterly Report on Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2024Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2024Q3 | us-gaap |
Cash
Cash
|
292861 | usd |
CY2024Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
42861 | usd |
CY2024Q3 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zaaXfFAYUU4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z7XT27f3Ywik">Concentrations of Risks</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Concentration of Accounts Receivable</span></i> – On September 30, 2024 and June 30, 2024, the Company had $<span id="xdx_909_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20240930_zQ9o6Zd8YFX9" title="Accounts receivables">156,610</span> and $<span id="xdx_90D_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20240630_zWTHeud49bxf" title="Accounts receivables">184,692</span> in accounts receivable, respectively. All of the accounts receivable at September 30, 2024 was from one supplier.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><i><span style="text-decoration: underline">Concentration of Revenues</span></i> – For the three months ended September 30, 2024 and 2023, the Company generated revenue of $<span id="xdx_900_eus-gaap--Revenues_c20240701__20240930_zUw5nXxWz3pc" title="Revenues">669,431</span> and $<span id="xdx_909_eus-gaap--Revenues_c20230701__20230930_z9ZbYlP4Zq27" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0536">-</span></span>, respectively. The Company’s revenue for the three months ended September 30, 2024 was largely attributable to revenue generated through 10 Fold Services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><i><span style="text-decoration: underline">Concentration of Suppliers</span></i> – For the three months ended September 30, 2024 and 2023, the Company had <span id="xdx_901_eus-gaap--PaymentsToSuppliers_c20240701__20240930_zH59w6O6KVlc" title="Payments to suppliers">2</span> and <span id="xdx_90E_eus-gaap--PaymentsToSuppliers_c20230701__20230930_zV5aqvwsIO59" title="Payments to suppliers">0</span> suppliers, respectively. The two suppliers, pharmaceutical compounding companies, are for the sales generated through 10 Fold Services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2024Q3 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
156610 | usd |
CY2024Q2 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
184692 | usd |
CY2024Q3 | us-gaap |
Revenues
Revenues
|
669431 | usd |
CY2024Q3 | us-gaap |
Payments To Suppliers
PaymentsToSuppliers
|
2 | usd |
CY2023Q3 | us-gaap |
Payments To Suppliers
PaymentsToSuppliers
|
0 | usd |
CY2024Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3000000000 | shares |
CY2023Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
29100000000 | shares |
CY2024Q3 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_848_eus-gaap--UseOfEstimates_ziGivDB5lgr6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zJ1hc78nMor7">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2024Q3 | us-gaap |
Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
|
5764227 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
156610 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
184692 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
156610 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
184692 | usd |
CY2024Q3 | GTLL |
Prepaid Deposits
PrepaidDeposits
|
225000 | usd |
CY2024Q2 | GTLL |
Prepaid Deposits
PrepaidDeposits
|
225000 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
225000 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
225000 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
|
36363 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
|
36363 | usd |
CY2024Q3 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
125000 | usd |
CY2024Q2 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
125000 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
161363 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
161363 | usd |
CY2024Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
40754 | usd |
CY2024Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
34756 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
120609 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
126607 | usd |
CY2024Q3 | us-gaap |
Depreciation
Depreciation
|
5998 | usd |
CY2023Q3 | us-gaap |
Depreciation
Depreciation
|
1298 | usd |
CY2024Q3 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
68269 | usd |
CY2024Q2 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
68269 | usd |
CY2024Q3 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
327947 | usd |
CY2024Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
327947 | usd |
CY2024Q3 | GTLL |
Preferred Stock Rank Description
PreferredStockRankDescription
|
All shares of the Series K Super Voting Preferred Stock shall rank (i) senior to the Corporation’s (A) Common Stock, par value $0.0001 per share (“Common Stock”), and any other class or series of capital stock of the Corporation hereafter created, except as otherwise provided in clauses (ii) and (iii) of this Section 4, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series K Super Voting Preferred-Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series K Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary | |
CY2024Q3 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
The holders of the Class A Shares and the Class B Shares shall vote as a single class on all matters submitted to a vote of the stockholders, with each Class A Share being entitled to one (1) vote and each Class B Share being entitled to six (6) votes, except as otherwise provided by law | |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-166409747 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
217114 | usd |
CY2024Q3 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |